BRWA
ALDX icon

B. Riley Wealth Advisors’s Aldeyra Therapeutics ALDX Stock Holding History

B. Riley Wealth Advisors’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,250
Closed -$76K – 1029
2020
Q3 		$76K Buy
+10,250
New +$66.2K ﹤0.01% 905
2020
Q2 		– Sell
-22,100
Closed -$55K – 865
2020
Q1 		$55K Sell
22,100
-3,000
-12% -$13.5K ﹤0.01% 754
2019
Q4 		$146K Buy
25,100
+2,650
+12% +$15.3K 0.01% 778
2019
Q3 		$119K Sell
22,450
-4,056
-15% -$21.8K 0.01% 765
2019
Q2 		$160K Sell
26,506
-500
-2% -$3.76K 0.02% 733
2019
Q1 		$244K Buy
27,006
+11,066
+69% +$94K 0.03% 585
2018
Q4 		$133K Buy
15,940
+2,000
+14% +$20.5K 0.02% 605
2018
Q3 		$193K Buy
+13,940
New +$113K 0.02% 651

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

B. Riley Wealth Advisors's ALDX Position: Q4 2020 in Review

B. Riley Wealth Advisors sold out of Aldeyra Therapeutics (ALDX) in Q4 2020, closing a stake of 10,250 shares — an estimated $76K sold.

B. Riley Wealth Advisors first reported a position in ALDX in Q3 2018 and held it in 8 quarters. The position peaked at $244K in Q1 2019. 98 funds tracked by Wall St. Rank hold ALDX as of Q4 2020.

  • B. Riley Wealth Advisors reported no remaining Aldeyra Therapeutics position as of Q4 2020 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 10,250 Aldeyra Therapeutics shares in Q4 2020, an estimated $76K.
  • B. Riley Wealth Advisors first reported a position in Aldeyra Therapeutics in Q3 2018 and held it in 8 quarters.
  • B. Riley Wealth Advisors's Aldeyra Therapeutics position peaked at $244K in Q1 2019.
  • 98 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q4 2020.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2020, filed 4 Feb 2021.